Patents by Inventor Gustavo Vera
Gustavo Vera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180296641Abstract: The present invention relates, e.g., to a method for inducing arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or for inducing mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte, comprising administering to a cell or tissue in need thereof a dose of a polynucleotide that encodes a vascular endothelial growth factor (VEGF), or that encodes a polypeptide comprising an active site of the VEGF. The coding sequence is operably linked to an expression control sequence; and the dose is sufficient to induce arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or to induce mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte. In preferred embodiments of the invention, the method is a method of tissue regeneration, particularly of cardiomyogenesis; and the polynucleotide (or a polypeptide encoded by such a polynucleotide) is administered into the myocardium.Type: ApplicationFiled: April 5, 2018Publication date: October 18, 2018Applicants: Sterrenbeld Biotechnologie North America, Inc., Fundacion Universitaria Dr. Rene G. FavaloroInventors: Ruben Laguens, Marcelo L. Arguelles, Gustavo Vera Janavel, Jose Alberto Crottogini, Carlos Alberto Melo, Ricardo Horacio Pichel, Marcelo Eduardo Criscuolo
-
Publication number: 20170252405Abstract: The present invention relates, e.g., to a method for inducing arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or for inducing mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte, comprising administering to a cell or tissue in need thereof a dose of a polynucleotide that encodes a vascular endothelial growth factor (VEGF), or that encodes a polypeptide comprising an active site of the VEGF. The coding sequence is operably linked to an expression control sequence; and the dose is sufficient to induce arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or to induce mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte. In preferred embodiments of the invention, the method is a method of tissue regeneration, particularly of cardiomyogenesis; and the polynucleotide (or a polypeptide encoded by such a polynucleotide) is administered into the myocardium.Type: ApplicationFiled: April 18, 2017Publication date: September 7, 2017Applicants: Sterrenbeld Biotechnologie North America, Inc., Fundacion Universitaria Dr. Rene G. FavaloroInventors: Ruben Laguens, Marcelo L. Arguelles, Gustavo Vera Janavel, Jose Alberto Crottogini, Carlos Alberto Melo, Ricardo Horacia Pichel, Marcelos Eduardo Criscuolo
-
Publication number: 20160346352Abstract: The present invention relates, e.g., to a method for inducing arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or for inducing mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte, comprising administering to a cell or tissue in need thereof a dose of a polynucleotide that encodes a vascular endothelial growth factor (VEGF), or that encodes a polypeptide comprising an active site of the VEGF. The coding sequence is operably linked to an expression control sequence; and the dose is sufficient to induce arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or to induce mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte. In preferred embodiments of the invention, the method is a method of tissue regeneration, particularly of cardiomyogenesis; and the polynucleotide (or a polypeptide encoded by such a polynucleotde) is administered into the myocardium.Type: ApplicationFiled: June 6, 2016Publication date: December 1, 2016Applicants: Sterrenbeld Biotechnologie North America, Inc., Fundacion Universitaria Dr. Rene G. FavaloroInventors: Ruben Laguens, Marcelo L. Arguelles, Gustavo Vera Janavel, Jose Alberto Crottogini, Carlos Alberto Melo, Ricardo Horacia Pichel, Marcelos Eduardo Criscuolo
-
Patent number: 9398754Abstract: Low-dust animal litters made from one or more ingredients that function as an animal litter and one or more polyols that function to control dust in the litter are described herein. The low-dust animal litters are made by selecting one or more litter ingredients suitable for making an animal litter and combining the litter ingredients with one or more polyols, generally by applying the polyols to the surface of one or more ingredients before or during the process of combining the ingredients to produce the litter.Type: GrantFiled: May 17, 2013Date of Patent: July 26, 2016Assignee: Nestec SAInventors: Yimin Zhang, Emily Alison Jemmott, Gustavo Vera
-
Publication number: 20140341972Abstract: The present invention relates, e.g., to a method for inducing arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or for inducing mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte, comprising administering to a cell or tissue in need thereof a dose of a polynucleotide that encodes a vascular endothelial growth factor (VEGF), or that encodes a polypeptide comprising an active site of the VEGF. The coding sequence is operably linked to an expression control sequence; and the dose is sufficient to induce arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or to induce mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte. In preferred embodiments of the invention, the method is a method of tissue regeneration, particularly of cardiomyogenesis; and the polynucleotide (or a polypeptide encoded by such a polynucleotde) is administered into the myocardium.Type: ApplicationFiled: February 10, 2014Publication date: November 20, 2014Applicants: Fundacion Universitaria Dr. Rene G. Favaloro, Sterrenbeld Biotechnologie North America, Inc.Inventors: RUBÉN LAGUENS, MARCELO L. ARGUELLES, GUSTAVO VERA JANAVEL, JOSÉ ALBERTO CROTTOGINI, CARLOS ALBERTO MELO, RICARDO HORACIA PICHEL, MARCELOS EDUARDO CRISCUOLO
-
Publication number: 20130319341Abstract: The invention provides low-dust animal litters made from one or more ingredients that function as an animal litter and one or more polyols that function to control dust in the litter. The low-dust animal litters are made by selecting one or more litter ingredients suitable for making an animal litter and combining the litter ingredients with one or more polyols, generally by applying the polyols to the surface of one or more ingredients before or during the process of combining the ingredients to produce the litter.Type: ApplicationFiled: May 17, 2013Publication date: December 5, 2013Applicant: Nestec SAInventors: Yimin Zhang, Emily Alison Jemmott, Gustavo Vera
-
Patent number: D807167Type: GrantFiled: January 29, 2016Date of Patent: January 9, 2018Assignee: NS Brands, Ltd.Inventors: J. Michael Joergensen, Lorraine Castillo, Gustavo Vera, Jacob Teitelbaum
-
Patent number: D853837Type: GrantFiled: January 4, 2018Date of Patent: July 16, 2019Assignee: NS Brands, Ltd.Inventors: J. Michael Joergensen, Lorraine Castillo, Gustavo Vera, Jacob Teitelbaum